Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 227476

Ketamine and the coagulation response during and after cardiopulmonary bypass.


Husedžinović, Ino; Barišin, Stjepan; Bradić, Nikola
Ketamine and the coagulation response during and after cardiopulmonary bypass. // Critical Care
Brisel, Belgija, 2005. (predavanje, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 227476 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Ketamine and the coagulation response during and after cardiopulmonary bypass.

Autori
Husedžinović, Ino ; Barišin, Stjepan ; Bradić, Nikola

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Critical Care / - , 2005

Skup
25th International Symposium on Intensive Care and Emergency Medicine

Mjesto i datum
Brisel, Belgija, 22. - 25. 03. 2005

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
coagulation; inflammation; cardiac surgery

Sažetak
INTRODUCTION. The inflammatory response and the coagulation-fibrinolytic cascades are closely interconnected. Vascular injury following cardiopulmonary bypass (CPB) may result in uncontrolled platelet activation, thrombin generation, and disseminated intravacular coagulation. Many of the anesthetic agents posses immunomodulatory effects. The clinical implications of such effects in the context of CPB remain unknown. Ketamine attenuates IL-6 response and production of the superoxide anion by neutrophils after CPB, and reduces coronary uptake of neutrophils following myocardial ishemia and reperfusion. We studied the effect of small dose ketamine on the coagulation response (antithrombin III, fibrinogen, D-dimers, platelets) during and after CPB. METHODS. In the preliminary prospective study report, we randomized 30 patients underwent open heart surgery in two groups: K-group (n=15), which received 0, 5 mg/kg ketamine, and P-group (n=15), which received placebo. Serum samples were collected before starting operation (T0), after aorta clamp releasing (T1), 30 min (T2), 2 (T3), 6 (T4), 12 (T5), 24 (T6), and 48 hours (T7) after weaning from CPB. Data (mean± ; SD) were done by variance analysis. RESULTS. Both group were comparable for age, sex, and body surface area. Differences of operative (CPB and aorta cross- clamping time), and postoperative date (ventilatory support, ICU stay, blood transfusion) between groups were not significant. Parameters Measurement T0 T1 T2 T3 T4 T5 T6 T7 CRP(mg/dl) K 3.6± ; 2.9 2.0± ; 1.6 2.6± ; 1.8 2.6± ; 2.1 8.4± ; 5.6 33.2± ; 17.0 104.7± ; 35.7 122.2± ; 53.3 P 5.0± ; 5.6 4.1± ; 5.6 4.1± ; 6.1 4.5± ; 6.9 11.5± ; 10.1 36.3± ; 18.3 102.9± ; 38.8 121.2± ; 52.3 WBC (x103) K 4.7± ; 1.4*‡ 8.3± ; 3.1 11.0± ; 2.4 11.4± ; 3.1 11.2± ; 3.6 10.1± ; 2.7 11.8± ; 2.9 10.9± ; 4.5 P 7.0± ; 3.1 8.9± ; 4.7 12.4± ; 3.9 12.3± ; 3.3 11.5± ; 3.0 10.1± ; 3.0 10.6± ; 2.9 8.7± ; 3.5 PMN (x103) K 3.1± ; 1.4 5.9± ; 2.8 9.1± ; 2.1 9.3± ; 2.7 9.7± ; 3.2 9.2± ; 3.1 10.3± ; 3.6 9.1± ; 4.1 P 4.5± ; 2.0 6.1± ; 3.1 10.1± ; 3.4 10.0± ; 2.4 9.9± ; 2.5 8.4± ; 2.1 8.7± ; 2.5 10.2± ; 8.7 Htc (%) K 0.35± ; 0.1 0.21± ; 0.0 0.29± ; 0.2 0.32± ; 0.2 0.33± ; 0.1 0.34± ; 0.2 0.34± ; 0.1 0.29± ; 0.3 P 0.40± ; 0.0 0.22± ; 0.0 0.30± ; 0.4 0.32± ; 0.3 0.33± ; 0.2 0.32± ; 0.3 0.33± ; 0.1 0.30± ; 0.1 Lactate (mmol/l) K 1.0± ; 0.1 2.1± ; 0.5 2.6± ; 0.6 2.5± ; 0.7 2.9± ; 1.0 2.5± ; 0.8 1.7± ; 0.8 1.1± ; 0.4 P 1.1± ; 0.3 2.0± ; 0.4 2.1± ; 0.3 2.1± ; 0.4 2.3± ; 0.8 2.0± ; 1.0 1.3± ; 0.5 1.1± ; 0.4 AT III (%) K 80.0± ; 9.5 50.9± ; 5.4 55.5± ; 7.8 57.4± ; 9.7 65.3± ; 12.4 66.5± ; 9.0 67.7± ; 5.6 67.9± ; 7.9 P 86.6± ; 14.8 57.3± ; 9.3 58.0± ; 14.0 71.3± ; 15.6 73.8± ; 10.8 75.0± ; 9.3 74.0± ; 10.2 72.7± ; 11.9 fibrinogen (g/L) K 3.3± ; 0.7 1.9± ; 0.3 2.0± ; 0.3 2.2± ; 0.3 2.4± ; 0.4 2.7± ; 0.5 3.6± ; 1.1 4.3± ; 1.5 P 3.3± ; 0.9 2.0± ; 0.4 2.2± ; 0.8 2.4± ; 0.4 2.7± ; 0.4 3.0± ; 0.5 4.3± ; 1.2 5.3± ; 1.3 D-dimers ( g/mL) K 0.3± ; 0.1 1.8± ; 1.3 2.9± ; 1.8 2.8± ; 1.7 2.5± ; 1.3 2.1± ; 1.3 1.6± ; 1.1 0.7± ; 0.2 P 0.5± ; 0.6 1.8± ; 1.5 3.3± ; 2.4 2.9± ; 2.3 2.1± ; 1.4 1.6± ; 0.9 1.4± ; 1.1 1.1± ; 0.9 Platelets (x103) K 173.0± ; 48.3 116.1± ; 39.9 99.7± ; 25.8 109.1± ; 32.6 117.0± ; 37.3 102.9± ; 39.3 96.2± ; 32.6 85.5± ; 23.4 P 170.1± ; 67.5 133.7± ; 56.9 100.1± ; 41.6 126.3± ; 44.8 145.5± ; 40.7 133.4± ; 38.7 121.2± ; 41.9 107.1± ; 44.4 *p<0.05 between groups ; ‡ p<0.05 within groups ; (K = ketamine group, P = placebo group) CONCLUSION. In this preliminary study, findings suggest that small doses of ketamine posses any effect on the coagulation response during and after CPB.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
0198019

Ustanove:
Klinička bolnica "Dubrava"

Profili:

Avatar Url Ino Husedžinović (autor)

Avatar Url Stjepan Barišin (autor)

Avatar Url Nikola Bradić (autor)


Citiraj ovu publikaciju

Husedžinović, Ino; Barišin, Stjepan; Bradić, Nikola
Ketamine and the coagulation response during and after cardiopulmonary bypass. // Critical Care
Brisel, Belgija, 2005. (predavanje, međunarodna recenzija, sažetak, znanstveni)
Husedžinović, I., Barišin, S. & Bradić, N. (2005) Ketamine and the coagulation response during and after cardiopulmonary bypass.. U: Critical Care.
@article{article, year = {2005}, pages = {62}, keywords = {coagulation, inflammation, cardiac surgery}, title = {Ketamine and the coagulation response during and after cardiopulmonary bypass.}, keyword = {coagulation, inflammation, cardiac surgery}, publisherplace = {Brisel, Belgija} }
@article{article, year = {2005}, pages = {62}, keywords = {coagulation, inflammation, cardiac surgery}, title = {Ketamine and the coagulation response during and after cardiopulmonary bypass.}, keyword = {coagulation, inflammation, cardiac surgery}, publisherplace = {Brisel, Belgija} }




Contrast
Increase Font
Decrease Font
Dyslexic Font